Therapeutic vaccines for preventing AIDS: their use with HAART

被引：8

作者：

Hoff, R ^{[1
]}

McNamara, J

机构：

[1] NIAID, Vaccine & Prevent Res Program, NIH, Bethesda, MD 20892 USA

[2] NIAID, Therapeut Res Program, Div Aids, NIH, Bethesda, MD 20892 USA

来源：

LANCET | 1999年 / 353卷 / 9166期

关键词：

D O I：

10.1016/S0140-6736(99)90025-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1723 / 1724

页数：2

共 14 条

[1] Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients [J].

Calarota, S ;

Bratt, G ;

Nordlund, S ;

Hinkula, J ;

Leandersson, AC ;

Sandström, E ;

Wahren, B .

LANCET, 1998, 351 (9112) :1320-1325

[2] Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand [J].

Churdboonchart, V ;

Moss, RB ;

Sirawaraporn, W ;

Smutharaks, B ;

Sutthent, R ;

Jensen, FC ;

Vacharak, P ;

Grimes, J ;

Theofan, G ;

Carlo, DJ .

AIDS, 1998, 12 (12) :1521-1527

[3]

Eron JJ, 1996, LANCET, V348, P1547

[4] Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals [J].

Klein, MR ;

Veenstra, J ;

Holwerda, AM ;

Roos, MTL ;

Gow, I ;

Patou, G ;

Coutinho, RA ;

DeWolf, F ;

Miedema, F .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (05) :393-399

[5] Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection [J].

Luzuriaga, K ;

Bryson, Y ;

Krogstad, P ;

Robinson, J ;

Stechenberg, B ;

Lamson, M ;

Cort, S ;

Sullivan, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (19) :1343-1349

[6] First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response [J].

MacGregor, RR ;

Boyer, JD ;

Ugen, KE ;

Lacy, KE ;

Gluckman, SJ ;

Bagarazzi, ML ;

Chattergoon, MA ;

Baine, Y ;

Higgins, TJ ;

Ciccarelli, RB ;

Coney, LR ;

Ginsberg, RS ;

Weiner, DB .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :92-100

[7] Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: Evaluation of the T cell proliferative response [J].

Ratto-Kim, S ;

Sitz, KV ;

Garner, RP ;

Kim, JH ;

Davis, C ;

Aronson, N ;

Ruiz, N ;

Tencer, K ;

Redfield, RR ;

Birx, DL .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (02) :337-344

[8]

Rinaldo CR, 1999, J INFECT DIS, V179, P329, DOI 10.1086/314599

[9] Vigorous HIV-1-specific CD4(+) T cell responses associated with control of viremia [J].

Rosenberg, ES ;

Billingsley, JM ;

Caliendo, AM ;

Boswell, SL ;

Sax, PE ;

Kalams, SA ;

Walker, BD .

SCIENCE, 1997, 278 (5342) :1447-1450

[10] A STRATEGY FOR PROPHYLACTIC VACCINATION AGAINST HIV [J].

SALK, J ;

BRETSCHER, PA ;

SALK, PL ;

CLERICI, M ;

SHEARER, GM .

SCIENCE, 1993, 260 (5112) :1270-1272

← 1 2 →